Latest Breaking News On - Davida mclain - Page 1 : comparemela.com

Congress of Clinical Rheumatology-East celebrates milestone 40th anniversary

Congress of Clinical Rheumatology-East celebrates milestone 40th anniversary
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of pennsylvaniaNoord hollandUniversity of floridaSandestin hiltonRuth ann vleugelsShenaz baghaMike lewieckiJason busseAnne marie malfaitVan vollenhovenAlexis ogdie beattyDavida mclainMegan eb clowseDoruk erkanPhilip seo

The Congress of Clinical Rheumatology-West goes Back to the Future in San Diego

The Congress of Clinical Rheumatology-West goes Back to the Future in San Diego
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoAl qahirahW winn chathamYvonnec leeJohn rp tesserJohnj cushLas vegasPhilipj measeShenaz baghaByrob volanskyDaniel wallaceLeonard calabreseAlan epsteinStephen zieglerElizabeth volkmann

New faces to bring expertise on biosimilars, complex diseases to CCR-East 2023

A collection of new presenters will be speaking at the 2023 Congress of Clinical Rheumatology-East, covering biosimilars and complex diseases under the rheumatology umbrella, including sarcoidosis and Sjögren’s syndrome. The new faces will join CCR-East veterans including Michelle Petri, MD, MPH, of Johns Hopkins Medicine, John Stone, MD, MPH, of Massachusetts General Hospital and Arthur

United statesUniversity of illinoisSan diegoCleveland clinicUniversity of massachusettsMelaine petersonByrob volanskyShenaz baghaNaderaj sweissLeonard calabreseDavid mclainDavida mclainDaniel aletahaSara mccoyArthur kavanaughMichelle petri

Tapering inferior to stable dose DMARDs for flare prevention in RA remission

Tapering conventional synthetic DMARDs to a half-dose was inferior to stable-dose regimens for preventing flares during a 1-year period among patients in rheumatoid arthritis remission, according to data published in JAMA.“Although [conventional synthetic DMARD (csDMARD)] therapy is commonly prescribed, the optimal method of dose reduction and withdrawal of csDMARD in RA is unclear,”

United statesDavida mclainSiri lillegravenAlabama society for the rheumatic diseasesDiakonhjemmet hospitalDisease activity scoreAlabama society